Research Funded

Mount Sinai Hospital, NYC: $100,000 for a fully personalized immunotherapy approach to GBM through Dr. Adilia Hormigo.

GBM AGILE: $500,000 for the world’s first global adaptive clinical trial platform for GBM in partnership with NBTS.

View Fullscreen